[Translation] A randomized, double-blind, placebo-controlled, dose-escalating, single-center Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetics of 0.5%, 1.0%, and 1.5% BT01001 eye drops in healthy adult subjects
1) 观察单剂量及多剂量给药的BT01001滴眼液的系统安全性及眼部安全性
2) 观察单剂量及多剂量给药的BT01001滴眼液的眼部耐受性
3) 探究BT01001药代动力学评价指标
[Translation] 1) Observe the systemic and ocular safety of BT01001 eye drops after single and multiple doses
2) Observe the ocular tolerance of BT01001 eye drops after single and multiple doses
3) Develop pharmacokinetic evaluation indicators for BT01001